Teachers Advisors’s NovoCure NVCR Stock Holding History

Teachers Advisors’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$7.84M	Buy	162,667 +15,058	+10%	+$725K	0.01%	1146
2018 Q4	$4.94M	Buy	147,609 +4,644	+3%	+$170K	0.01%	1309
2018 Q3	$7.49M	Buy	142,965 +2,712	+2%	+$108K	0.01%	1218
2018 Q2	$4.39M	Buy	140,253 +11,700	+9%	+$325K	0.01%	1494
2018 Q1	$2.8M	Buy	128,553 +24,023	+23%	+$517K	﹤0.01%	1628
2017 Q4	$2.11M	Hold	104,530	–	–	﹤0.01%	1808
2017 Q3	$2.08M	Buy	104,530 +265	+0.3%	+$5.21K	﹤0.01%	1819
2017 Q2	$1.8M	Buy	104,265 +5,466	+6%	+$70.6K	﹤0.01%	1884
2017 Q1	$800K	Buy	98,799 +3,125	+3%	+$22.6K	﹤0.01%	2306
2016 Q4	$751K	Buy	95,674 +16,741	+21%	+$135K	﹤0.01%	2327
2016 Q3	$674K	Sell	78,933 -1,996	-2%	-$18.2K	﹤0.01%	2305
2016 Q2	$944K	Buy	80,929 +69,815	+628%	+$874K	﹤0.01%	2059
2016 Q1	$161K	Buy	11,114 +2,426	+28%	+$34.8K	﹤0.01%	2847
2015 Q4	$194K	Buy	+8,688	New	+$208K	﹤0.01%	2878

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DCP

Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Teachers Advisors's NVCR Position: Q1 2019 in Review

Teachers Advisors increased its NovoCure (NVCR) stake by 10% in Q1 2019, buying an estimated $725K and bringing the position to 162,667 shares worth $7.84M. The position accounts for 0.01% of the portfolio, ranked #1146.

Teachers Advisors first reported a position in NVCR in Q4 2015 and has held it in 14 quarters since. 200 funds tracked by Wall St. Rank hold NVCR as of Q1 2019.

Teachers Advisors held 162,667 shares of NovoCure worth $7.84M as of Q1 2019.
Teachers Advisors bought 15,058 NovoCure shares in Q1 2019, an estimated $725K.
NovoCure made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #1146 holding.
Teachers Advisors first reported a position in NovoCure in Q4 2015 and has held it in 14 quarters since.
200 funds tracked by Wall St. Rank held NovoCure as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.